PAI

Palo Alto Investors Portfolio holdings

AUM $470M
This Quarter Return
-0.06%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.32B
AUM Growth
+$1.32B
Cap. Flow
+$65M
Cap. Flow %
4.91%
Top 10 Hldgs %
68.37%
Holding
46
New
2
Increased
28
Reduced
2
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SAGE
26
DELISTED
Sage Therapeutics
SAGE
$12.6M 0.95%
+417,878
New +$12.6M
RIGL icon
27
Rigel Pharmaceuticals
RIGL
$710M
$12M 0.91%
5,386,534
+155,615
+3% +$347K
SQNM
28
DELISTED
SEQUENOM INC NEW
SQNM
$9.43M 0.71%
10,322,377
+298,535
+3% +$273K
EXAS icon
29
Exact Sciences
EXAS
$9.33B
$4.85M 0.37%
396,276
TLPH icon
30
Talphera
TLPH
$11.2M
$3.83M 0.29%
1,425,439
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.82M 0.29%
6,974,854
ALIM
32
DELISTED
Alimera Sciences, Inc.
ALIM
$3.71M 0.28%
3,013,793
AIMT
33
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$3.52M 0.27%
325,599
ALGN icon
34
Align Technology
ALGN
$9.59B
$2.93M 0.22%
36,357
+8,600
+31% +$693K
ACGN
35
DELISTED
Aceragen, Inc. Common Stock
ACGN
$1.92M 0.15%
1,257,748
ARCT icon
36
Arcturus Therapeutics
ARCT
$467M
$1.23M 0.09%
272,788
+18,600
+7% +$83.5K
CYTK icon
37
Cytokinetics
CYTK
$5.98B
$1.17M 0.09%
123,686
PGEN icon
38
Precigen
PGEN
$1.42B
$1.16M 0.09%
47,100
SPHS
39
DELISTED
Sophiris Bio, Inc.
SPHS
$1.06M 0.08%
494,000
DRNA
40
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$804K 0.06%
267,890
OCGN icon
41
Ocugen
OCGN
$328M
$777K 0.06%
454,545
OREX
42
DELISTED
Orexigen Therapeutics, Inc.
OREX
$719K 0.05%
1,673,024
ZGNX
43
DELISTED
Zogenix, Inc.
ZGNX
$237K 0.02%
29,500
+900
+3% +$7.23K
QURE icon
44
uniQure
QURE
$954M
$151K 0.01%
20,453
MRNS
45
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$81K 0.01%
63,517
+4,500
+8% +$5.74K
ANAC
46
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
-2,219,042
Closed -$119M